Parexel Parexel @Parexel

RT @HealthAdvances: To understand market access issues facing rare disease products in England, Kelly Cockerill, Director @HealthAdvances, led a podium presentation at #ISPORBarcelona to present findings from the first 5 years of the NICE HST program. Find out more:

6:24 PM - 14 Nov 18
Previous Tweet

RT @JdeBetts: Our opportunities for CRAs span many countries. We're looking forward to connecting with pros...

Next Tweet

FDA Inspection Processes: What should you anticipate? PAREXEL's Robert Iser dives into this issue at this y...


Register now for full access to all the content

First Name
Last Name
Company Name
Thank you for registering!
Error - something went wrong!